Postma, who holds a Ph.D. in signal transduction from the Netherlands Cancer Institute, transitioned to AI from wearable digital health devices. “I quickly found out that it’s very important to be able to contextualize AI,” he explains.
Now, Postma, trained as a biologist and electrophysiologist, that experience in contextualizing AI has been instrumental in developing and continuously refining an end-to-end platform for drug re-innovation, focusing on neurological rare and psychiatric disorders. This platform, which he helped create, is now central to his ongoing work. “Interestingly, I’m not a data scientist or an AI engineer, …